Evidence map›Paper›PMID 38822068›Full record

ArticleScientific reports2024

Pulsed electric field induces exocytosis and overexpression of MAGE antigens in melanoma.

Wojciech Szlasa, Natalia Sauer, Dagmara Baczyńska, Marcin Ziętek, Katarzyna Haczkiewicz-Leśniak, Paweł Karpiński, Mariusz Fleszar, Paulina Fortuna, Michał J Kulus, Aleksandra Piotrowska and 10 more

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Current Research in Drug-Free Cancer Therapies.Bioengineering (Basel, Switzerland) · 2025
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Wojciech SzlasaMedical University Hospital, Borowska 213, 50-556, Wrocław, Poland. wojciech.szlasa@outlook.com.
Natalia SauerFaculty of Pharmacy, Wroclaw Medical University, Wroclaw, Poland.
Dagmara BaczyńskaDepartment of Molecular and Cellular Biology, Faculty of Pharmacy, Wroclaw Medical University, Wroclaw, Poland.
Marcin ZiętekDepartment of Surgical Oncology, Wroclaw Comprehensive Cancer Center, Wroclaw, Poland.
Katarzyna Haczkiewicz-LeśniakDivision of Ultrastructural Research, Faculty of Medicine, Wroclaw Medical University, 50-368, Wroclaw, Poland.
Paweł KarpińskiDepartment of Genetics, Wroclaw Medical University, Wroclaw, Poland.
Mariusz FleszarDepartment of Medical Biochemistry, Wroclaw Medical University, Wroclaw, Poland.
Paulina FortunaDepartment of Medical Biochemistry, Wroclaw Medical University, Wroclaw, Poland.
Michał J KulusDivision of Ultrastructural Research, Faculty of Medicine, Wroclaw Medical University, 50-368, Wroclaw, Poland.
Aleksandra PiotrowskaDivision of Histology and Embryology, Department of Human Morphology and Embryology, Wroclaw, Poland.
Alicja KmiecikDivision of Histology and Embryology, Department of Human Morphology and Embryology, Wroclaw, Poland.
Agnieszka BarańskaDivision of Histology and Embryology, Department of Human Morphology and Embryology, Wroclaw, Poland.
Olga MichelDepartment of Molecular and Cellular Biology, Faculty of Pharmacy, Wroclaw Medical University, Wroclaw, Poland.
Vitalij NovickijFaculty of Electronics, Vilnius Gediminas Technical University, 03227, Vilnius, Lithuania.
Mounir TarekUniversité de Lorraine, CNRS, LPCT, 54000, Nancy, France.
Paulina KasperkiewiczDepartment of Chemical Biology and Bioimaging, Faculty of Chemistry, Wroclaw University of Science and Technology, Wroclaw, Poland.
Piotr DzięgielDivision of Histology and Embryology, Department of Human Morphology and Embryology, Wroclaw, Poland.
Marzenna Podhorska-OkołówDivision of Ultrastructural Research, Faculty of Medicine, Wroclaw Medical University, 50-368, Wroclaw, Poland.
Jolanta SaczkoDepartment of Molecular and Cellular Biology, Faculty of Pharmacy, Wroclaw Medical University, Wroclaw, Poland.
Julita KulbackaDepartment of Molecular and Cellular Biology, Faculty of Pharmacy, Wroclaw Medical University, Wroclaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanosecond pulsed electric field (nsPEF) has emerged as a promising approach for inducing cell death in melanoma, either as a standalone treatment or in combination with chemotherapeutics. However, to date, there has been a shortage of studies exploring the impact of nsPEF on the expression of cancer-specific molecules. In this investigation, we sought to assess the effects of nsPEF on melanoma-specific MAGE (Melanoma Antigen Gene Protein Family) expression. To achieve this, melanoma cells were exposed to nsPEF with parameters set at 8 kV/cm, 200 ns duration, 100 pulses, and a frequency of 10 kHz. We also aimed to comprehensively describe the consequences of this electric field on melanoma cells' invasion and proliferation potential. Our findings reveal that following exposure to nsPEF, melanoma cells release microvesicles containing MAGE antigens, leading to a simultaneous increase in the expression and mRNA content of membrane-associated antigens such as MAGE-A1. Notably, we observed an unexpected increase in the expression of PD-1 as well. While we did not observe significant differences in the cells' proliferation or invasion potential, a remarkable alteration in the cells' metabolomic and lipidomic profiles towards a less aggressive phenotype was evident. Furthermore, we validated these results using ex vivo tissue cultures and 3D melanoma culture models. Our study demonstrates that nsPEF can elevate the expression of membrane-associated proteins, including melanoma-specific antigens. The mechanism underlying the overexpression of MAGE antigens involves the initial release of microvesicles containing MAGE antigens, followed by a gradual increase in mRNA levels, ultimately resulting in elevated expression of MAGE antigens post-experiment. These findings shed light on a novel method for modulating cancer cells to overexpress cancer-specific molecules, thereby potentially enhancing their sensitivity to targeted anticancer therapy.

Indexed as

ExocytosisMelanomaMelanoma-Specific AntigensAntigens, NeoplasmCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticHumansAntigens, NeoplasmMelanoma-Specific AntigensFocal treatmentMAGEMelanomaMicrovesiclesNanosecond pulsed electric fieldPD-1

Identifiers

PMID38822068
PMCPMC11143327

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.